CooperCompanies to acquire Cook Medical's Reproductive Health business for $875M

COOPER COMPANIES, INC.

Deal consideration: $675M at closing plus $200M in four $50M annual installments.
Cook's Reproductive Health had ~$158M revenue in 2021, up ~17% YoY in constant currency.
Expected to be accretive to non-GAAP EPS by ~$0.60 in the first year after closing.
Acquisition enhances CooperSurgical's international fertility footprint and ObGyn device portfolio.
Closing subject to regulatory approvals, definitive agreement, and local consultation requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.